Citation Information :
Singh M, Mahal GB, Chander R. A Prospective Evaluation of Acute Cerebral Ischemic Stroke by Conventional and Diffusion-Weighted MR Imaging Sequences. Curr Trends Diagn Treat 2018; 2 (2):77-81.
Aim: The aim of this study is to compare the diffusion-weighted magnetic resonance imaging (DW-MRI) with conventional MRI in the evaluation of acute cerebral ischemic stroke.
Materials and methods: In this prospective study, for 2 years, 50 patients who were clinically suspected cases of acute ischemic stroke (AIS) underwent MRI using a 1.5 tesla scanner (SIEMEN MAGNETOM Aera) in the Department of Radiodiagnosis, Guru Nanak Dev Medical College, Amritsar, Punjab. The patients from all age groups and both sexes were included in this study.
Results: In our study of 50 cases, the age range of patients was from 2 years to 80 years with a majority of 40 (90%) patients above 40 years age with 32 (64%) males and 18 (36%) females. About 20 (40%) patients presented with weakness/numbness on either side. The conventional MRI had a sensitivity of 50% in detecting stroke in patients presented within 3 hours of the onset of symptoms, while DW-MRI had a sensitivity of 100%. For the patients presented within 3 to 6 hours, conventional MRI and DWI had a sensitivity of 66% and 100%; for the patients presented within 6 to 12 hours, conventional MRI and DWI had a sensitivity of 85% and 100%, and for patients presented within 12 to 24 hours, conventional MRI and DWI had a sensitivity of 92.3% and 100%, respectively. The middle cerebral artery (MCA) was the most commonly involved territory.
Conclusion: The DW sequence is the sensitive modality in the diagnostic evaluation of acute stroke as compared to conventional MRI sequences. It plays a pivotal role in the localization and characterization of acute ischemic lesions and, hence, effective and early treatment with thrombolytic therapy is needed.
Aho K, Harmsen P, Hatano S et al. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58(1):113-330.
A classification and outline of cerebrovascular diseases. II. Stroke 1975;6(5):564-516.
Kasmaei HD, Baratloo A, Nasiri Z et al. Recombinant Tissue Plasminogen Activator Administration in Patients with Cerebrovascular Accident a case series. Archives of Neuroscience 2015;2(2):23315-23318.
Lin MP, Liebeskind DS. Imaging of ischemic stroke. Continuum (Minneap Minn) Neuroimaging 2016;22(5):1399-1423.
Allen LM, Hasso AN, Handwerker J et al. Sequence-specific MR Imaging Findings That Are Useful in Dating Ischemic Stroke. Radio Graphics 2012;32(5):1285-1297.
Kunz A, Hahn G, Mucha D et al. Echo-enhanced transcranial color-coded duplex sonography in the diagnosis of cerebrovascular events: a validation study. AJNR Amj Neuroradiol 2006;27(10):2122-2127.
McGraw-Hill. Emergency Radiology: Case Studies Access Emergency Medicine. Medicalbook 2008;8:434-461.
Khandelwal P, Yavagal DR, Sacco RL. Acute ischemic stroke Intervention. Journal of the American College of Cardiology 2016;67(22):2631-2644.
Del Zappo GJ, Saver JL, Jauch EC. For the American Heart Associate statistics committee and stroke statistics subcommittee. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator a science advisory from the American Heart Association/ American Stroke Association. Stroke 2009;40(8):2945-2948.
Roger VL, Go AS, Lloyd-Jones DM et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2011;123(4):18-19.
Appelros P, Stegmayr B, Teréntm A. Sex differences in stroke epidemiology a systematic review stroke. 2009;40(4):1082-1089.
Reeves MJ, Bushnell CD, Howard G et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008;7(10):915-926.
Nagaraja D, Gururaj G, Girish N et al. Feasibility study of stroke surveillance data from Bangalore, India. Indian J Med Res 2009;130(4):396-403.
Lees KR, Bluhmki E, von Kummer R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375(9727):1695-1703.
N Engl. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for Acute ischemic stroke. J Med 1995;333(24):1581-1587.
Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial Stroke.1997;28(11):2119-2125.
Paciaroni M, Silvestrelli G, Caso V et al. Neurovascular territory involved in different etiological subtypes of ischemic stroke in the Perugia Stroke Registry. Eur J Neurol 2003;10(4):361-365.
Nisar S, Nizami AA, Khan SF. Accuracy of diffusion-weighted magnetic resonance imaging in the detection of acute cerebral infarcts. P J M H S 2014:(8):832-836.
Rosso C, Drier A, Lacroix D et al. Diffusion-weighted MRI in acute stroke within the first 6 hours Neurology. 2010;74(24):1946-1953.
Warach S, Gaa J, Siewert B et al. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37(2):231-241.
Merino JG, Warach S. Imaging of acute stroke. Nat Rev Neurol 2010;6(10):560-571.
O'Brien P, Sellar RJ, Wardlaw JM. Fogging on T2-weighted MR after acute ischaemic stroke: how often might this occur and what are the implications. Neuroradiology 2004;46(8):635-641.
Nah HW, Kang DW, Kwon SU et al. Diversity of single small subcortical infarctions according to infarct location and parent artery disease: analysis of indicators for small vessel disease and atherosclerosis. Stroke 2010;41(12):2822-2827.
Aoki J, Kimura K, Iguchi Y et al. FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci 2010;293(1-2):39-44.